PT2998305T - Cristal de sal de lítio de pirroloquinolina quinona e seu método de preparação e aplicação - Google Patents

Cristal de sal de lítio de pirroloquinolina quinona e seu método de preparação e aplicação

Info

Publication number
PT2998305T
PT2998305T PT148194186T PT14819418T PT2998305T PT 2998305 T PT2998305 T PT 2998305T PT 148194186 T PT148194186 T PT 148194186T PT 14819418 T PT14819418 T PT 14819418T PT 2998305 T PT2998305 T PT 2998305T
Authority
PT
Portugal
Prior art keywords
preparation
application
lithium salt
salt crystal
pyrroloquinoline quinone
Prior art date
Application number
PT148194186T
Other languages
English (en)
Original Assignee
Shanghai Ri Xin Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ri Xin Biotechnology Co Ltd filed Critical Shanghai Ri Xin Biotechnology Co Ltd
Publication of PT2998305T publication Critical patent/PT2998305T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
PT148194186T 2013-07-01 2014-06-23 Cristal de sal de lítio de pirroloquinolina quinona e seu método de preparação e aplicação PT2998305T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310270885.2A CN103351387B (zh) 2013-07-01 2013-07-01 吡咯喹啉醌锂盐晶体及其制备方法和应用

Publications (1)

Publication Number Publication Date
PT2998305T true PT2998305T (pt) 2020-07-09

Family

ID=49307822

Family Applications (1)

Application Number Title Priority Date Filing Date
PT148194186T PT2998305T (pt) 2013-07-01 2014-06-23 Cristal de sal de lítio de pirroloquinolina quinona e seu método de preparação e aplicação

Country Status (8)

Country Link
US (1) US9738639B2 (pt)
EP (1) EP2998305B1 (pt)
JP (1) JP6130595B2 (pt)
CN (1) CN103351387B (pt)
ES (1) ES2794078T3 (pt)
PL (1) PL2998305T3 (pt)
PT (1) PT2998305T (pt)
WO (1) WO2015000370A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017114844A (ja) * 2015-12-22 2017-06-29 三菱瓦斯化学株式会社 認識能力向上食品
CN112274513B (zh) * 2020-12-28 2021-03-26 上海日馨生物科技有限公司 含有吡咯喹啉醌三锂盐九水化合物的药物组合物、胶囊剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101193888A (zh) * 2005-03-24 2008-06-04 Clf医疗技术加速程序有限公司 吡咯喹啉醌(pqq)的合成方法
US20100190815A1 (en) 2006-09-08 2010-07-29 Kyowa Hakko Bio Co., Ltd. Hypertension-ameliorating agent
CN101851234A (zh) * 2009-04-03 2010-10-06 上海日馨生物科技有限公司 吡咯喹啉醌锂盐衍生物及其制备方法
CN101885725A (zh) * 2009-05-12 2010-11-17 江苏道琪生物科技有限公司 吡咯喹啉醌钠盐衍生物及其制备方法
JP2011026812A (ja) 2009-07-23 2011-02-10 Mano Kogyo Kk 引込管の施工方法
JP5636671B2 (ja) * 2009-12-17 2014-12-10 三菱瓦斯化学株式会社 ピロロキノリンキノンLi塩の製造方法

Also Published As

Publication number Publication date
BR112015031797A2 (pt) 2017-07-25
WO2015000370A1 (zh) 2015-01-08
JP2016522224A (ja) 2016-07-28
JP6130595B2 (ja) 2017-05-17
US20160137641A1 (en) 2016-05-19
ES2794078T3 (es) 2020-11-17
PL2998305T3 (pl) 2020-11-02
CN103351387B (zh) 2016-03-02
EP2998305A4 (en) 2017-01-04
EP2998305A1 (en) 2016-03-23
CN103351387A (zh) 2013-10-16
US9738639B2 (en) 2017-08-22
EP2998305B1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
EP3068240A4 (en) Theacrine-based supplement and method of use thereof
EP3089989A4 (en) Cas9 crystals and methods of use thereof
HRP20181704T1 (hr) Kristalni oblik kidamida, metoda pripreme i uporabe istog
ZA201503159B (en) Small crystal ferrierite and method of making the same
SG10202007643SA (en) Stable crystal form of tipiracil hydrochloride and crystallization method for the same
EP3050191A4 (en) Apparatus and method to change current limit
EP2918585A4 (en) Pyrroloquinoline-DINATRIUMSALZKRISTALL
EP2980178A4 (en) SEALANT AND MANUFACTURING METHOD THEREFOR
EP2824182A4 (en) PROCESS FOR STIMULATING T-CELLS AND USE THEREOF
SG11201507897SA (en) Salt of pyrazoloquinoline derivative, and crystal thereof
EP2826749A4 (en) LITHIUM TITANATE, AND METHOD OF PREPARATION AND USE THEREOF
HRP20190317T1 (hr) Kristalni oblik (6s)-5-metiltetrahidrofolatne soli i metoda za pripremanje istog
IL245272A0 (en) pif-transfected cells and methods of use
EP2958985A4 (en) ELECTROPORATION METHODS AND DEVICES
IL234492A (en) Crystalline forms of 5α - androstane - 3 β, 56β, - triol and methods for their preparation
PT2998305T (pt) Cristal de sal de lítio de pirroloquinolina quinona e seu método de preparação e aplicação
EP3033795A4 (en) Lithium sulfur cell and preparation method
EP2972573A4 (en) ELECTROCHROME DEVICES WITH VARIABLE EMITTANCE AND METHOD FOR THE PRODUCTION THEREOF
SG11201507073UA (en) Method for manufacturing liquid-crystal display cells and liquid-crystal display cells obtained via said method
EP2853555A4 (en) FILM AND ITS PREPARATION METHOD
EP3021414A4 (en) Nonaqueous electrolyte solution kit and method for preparing nonaqueous electrolyte solution
EP3000807A4 (en) Mercaptonicotinic acid compound and preparation method and use thereof
AP3759A (en) Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same
EP3067403A4 (en) Sealant composition and preparation method therefor
HK1248213A1 (zh) Abexinostat 甲苯磺酸鹽及相關的晶體形式的製備方法